This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
13 Mar 2013

Enrollment completed for next phase of lung cancer clinical trial

Enrollment has been completed for a Phase 2b clinical trial of a lung cancer drug candidate.

 

Biothera has announced completion of its enrollment programme for the 90-patient Phase 2b clinical trial of Imprime PGG byacizumab.

Related News